Cooper McIntosh
Internal Medicine · Oxford, MSNPI 1780791004
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 310 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,623 and has fallen 96.3% since, to $61 in 2025.
Across 310 payments — averaging $13.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$626
- AstraZeneca$535
- AbbVie$323
- Novo Nordisk$311
- Novartis$303
- Boehringer Ingelheim$300
- plus $2K from 21 others
What the payments were for
- Food & beverage$4,074100%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 52 | $626 |
| AstraZeneca | 34 | $535 |
| AbbVie(2 entities) | 26 | $323 |
| Novo Nordisk | 31 | $311 |
| Novartis | 22 | $303 |
| Boehringer Ingelheim | 18 | $300 |
| Merck | 19 | $258 |
| Pfizer | 23 | $250 |
| Amarin Pharma, Inc. | 14 | $210 |
| Astellas Pharma US Inc | 13 | $200 |
| Amgen | 16 | $189 |
| Lilly USA, LLC | 8 | $99 |
| Daiichi Sankyo Inc. | 4 | $71 |
| Avanir Pharmaceuticals, Inc. | 5 | $61 |
| Sunovion Pharmaceuticals Inc. | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $47 |
| Assertio Therapeutics, Inc. | 3 | $37 |
| GSK | 3 | $34 |
| Dexcom, Inc. | 2 | $27 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| Ironwood Pharmaceuticals, Inc | 2 | $27 |
| Hikma Pharmaceuticals USA | 1 | $22 |
| Eyevance Pharmaceuticals LLC | 1 | $22 |
| Melinta Therapeutics, LLC | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Mylan Specialty L.p. | 1 | $11 |
How this compares
$4,084 in reported general payments places this provider in the 85th percentile of 846 internal medicine providers in Mississippi.
Other internal medicine in Oxford
- Jeffrey DennisOxford$15K
- Charles HillOxford$15K
- Milton HobbsOxford$8K
- Kelly WilkinsonJackson$79K
- Shanna PettieJackson$53K
- Gabriel HernandezJackson$41K
- Indira VeerisettyRidgeland$25K
- James BridgesMadison$23K
- Brendan RossJackson$19K
- Hassan CheemaJackson$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.